BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) sold 3.4% of their position (1.69K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $14.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/18/2025ACC: 0000950170-25-096917
Officer· Principal Accounting Officer
Since Feb 2026
-1.69K
Net shares
Net seller
$14.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.69K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.69K
Price / share
$8.36
Trade value
$14.15K
% of position
3.4%
7/16/2025
50.08K→48.39K
Total
Net shares
−1.69K
Net value
-$14.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2025 | S · Sale | −1.69K | $8.36 | $14.15K | 3.4% | 50.08K | 48.39K |
| Total | −1.69K | -$14.15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.11K
Total
5.11K indirect5.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.11K | Indirect |
| Total | 5.11K | 5.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported